Award
National Cancer Institute 5U54CA272688-04
Lynch Vaccine
Recipient
National Cancer Institute (NCI)
Award Amount
$651,492.00
Ceiling
$651,492.00
Awarded
September 01, 2025
Identifier
5U54CA272688-04
Award for research on Lynch syndrome vaccine development by the National Cancer Institute, aiming to reduce tumor burden and improve survival in mouse models.
Description
The project focuses on Lynch syndrome and vaccine development targeting recurrent neoantigens. The project involves sequencing, vaccine candidate identification, and immunogenicity testing. The funding is provided by the National Cancer Institute, part of NIH. The project aims to reduce tumor burden and increase survival in LS mouse models. The project will inform future clinical trials and vaccine development.